SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ZymoGenetics ZGEN
An SI Board Since February 2002
Posts SubjectMarks Bans Symbol
210 12 0 ZGEN
Emcee:  Mike McFarland Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
135I believe we are in agreement that the thrombin market will shift from bovine toidos-6/6/2008
134Atacicept RA P1b trial results (the PR was never posted here; here's a coupltuck-6/5/2008
133[rThrombin appears to acheive more rapid hemostasis than pThrombin in peripheraltuck-6/5/2008
132[Interleukin 21 enhances antibody-mediated tumor rejection] >> Cancer Restuck-6/5/2008
131[IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM andtuck-6/5/2008
130[Interleukin-21 augments the efficacy of T-cell therapy by eliciting concurrent tuck-6/5/2008
129>>ZymoGenetics Announces FDA Approval of RECOTHROM(TM) 20,000-IU Vial Sizetuck-5/27/2008
128that would be my read too -- as a potential typo...mopgcw-5/23/2008
127I assume that last sentence should read: "However, we do <b>not</bmarthambles-5/23/2008
126Biotech Wrap Up of Citi Healthcare Conference 22 May 2008 15 Citigroup Global Mamopgcw-5/23/2008
125PDUFA date this Sunday for 20,000IU vials and spray kits, per today's webcastuck-5/21/2008
124>>ZymoGenetics Announces Publication of Five IL-21 ASCO Abstracts Thursdaytuck-5/20/2008
123OMRI - Thrombin war. Biosurgicals (Evicel and Evithrom) 1Q sales rose more thanidos-5/10/2008
122Competitive pressure didn't hurt KG's Thrombin-JMI sales of $67M (+5%), idos-5/8/2008
121In the CC they said that 22 out of 60 hospitals P&T committees converted froidos-5/7/2008
120ZGEN beats on revenues -- not much in Recothrom sales-- but more than Omrix is ttuck-5/6/2008
119RECOTHROM <i>It is not derived from animal or human blood.</i> a lSteve Lokness-4/30/2008
118ZymoGenetics Presents Positive Results from RECOTHROM(TM) Thrombin, topical (RecLJM-4/30/2008
117>>Merck Serono and ZymoGenetics Initiate Atacicept Phase 2 Clinical Trial tuck-4/30/2008
116OMRI had an analyst day today. They issued initial guidance for biosurgery salesidos-3/27/2008
115Forbes: ZymoGenetics Wins Over Warburg Ruthie Ackerman, 03.12.08, 6:25 PM ET Wmopgcw-3/20/2008
114The 21st-century analogue of a high-end horse-drawn carriage with all the bells DewDiligence_on_SI-3/11/2008
113<i>no impact from Evithrom and Recothrom was shown on Thrombin-JMI sales &Clarksterh-3/7/2008
112I think that this statement was one reason for yesterday's collapse: "Iidos-3/7/2008
111Omrix CC transcript, thanks to SeekingAlpha: seekingalpha.com "ETHICONtuck-3/6/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News